ImCyse (Belgium)

Recent papers from ImCyse (Belgium)

1. RECLAIM—A retrospective, multicenter observational study aimed at enabling the development of artificial intelligence-driven prognostic models for disease progression in multiple sclerosisFrontiers in Neurology · 2025
2. A future of AI-driven personalized care for people with multiple sclerosisFrontiers in Immunology · 2024
3. First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes: an exploratory analysis of immune biomarkersBMC Medicine · 2024
4. Thioreductase-Containing Epitopes Inhibit the Development of Type 1 Diabetes in the NOD Mouse ModelFrontiers in Immunology · 2016
5. Suppression of Immune Response to Adenovirus Serotype 5 Vector by Immunization with Peptides Containing an MHC Class II Epitope and a Thio-Oxidoreductase MotifHuman Gene Therapy · 2015
6. MHC Class II-Restricted Epitopes Containing an Oxidoreductase Activity Prompt CD4+ T Cells with Apoptosis-Inducing PropertiesFrontiers in Immunology · 2015